title: Functional requirements for inhibition of thrombin by antithrombin III in the presence and absence of heparin.
abstract: Mutation of 79 highly exposed amino acids that comprise approximately 62% of the solvent accessible surface of thrombin identified residues that modulate the inhibition of thrombin by antithrombin III, the principal physiological inhibitor of thrombin. Mutations that decreased the susceptibility of thrombin to inhibition by antithrombin III in the presence and absence of heparin (W50A, E229A, and R233A) also decreased hydrolysis of a small tripeptidyl substrate. These residues were clustered around the active site cleft of thrombin and were predicted to interact directly with the "substrate loop" of antithrombin III. Despite the large size of antithrombin III (58 kDa), no residues outside of the active cleft were identified that interact directly with antithrombin III. Mutations that decreased the susceptibility of thrombin to inhibition by antithrombin III in the presence but not in the absence of heparin (R89A/R93A/E94A, R98A, R245A, K248A, K252A/D255A/Q256A) in general did not also affect hydrolysis of the tripeptidyl substrate. These residues were clustered among a patch of basic residues on a surface of thrombin perpendicular to the face containing the active site cleft and were predicted to interact directly with heparin. Three mutations (E25A, R178A/R180A/D183A, and E202A) caused a slight enhancement of inhibition by antithrombin III.
authors.affiliation: Gilead Sciences, Foster City, California 94404, USA.
authors.forename: M
authors.initials: M
authors.lastname: Tsiang
authors.forename: A K
authors.initials: AK
authors.lastname: Jain
authors.forename: C S
authors.initials: CS
authors.lastname: Gibbs
mesh_terms: D000595:Amino Acid Sequence; D000990:Antithrombin III / Q000494:pharmacology*; D003001:Cloning, Molecular; D006493:Heparin / Q000494:pharmacology*; D006801:Humans; D007700:Kinetics; D008958:Models, Molecular; D016297:Mutagenesis, Site-Directed; D017354:Point Mutation; D011487:Protein Conformation; D011516:Prothrombin / Q000096:biosynthesis / Q000737:chemistry; D011994:Recombinant Proteins / Q000037:antagonists & inhibitors / Q000737:chemistry; D013917:Thrombin / Q000037:antagonists & inhibitors* / Q000737:chemistry*
chemical_list: D011994:Recombinant Proteins; D000990:Antithrombin III; D011516:Prothrombin; D006493:Heparin; D013917:Thrombin